Previous Article | Next Article ![]()
Infect. Immun., 04 1996, 1385-1390, Vol 64, No. 4
N Muller, S Stager and B Gottstein
Neonatal ZU.ICR mice were infected with trophozoites of Giardia lamblia
clone GS/M-83-H7 expressing the variant surface protein (VSP) H7 and were
subsequently investigated for their serum antibody response directed
against VSPH7. Recombinant polypeptides, representing overlapping segments
of VSPH7, and native Giardia proteins were used as antigenic reagents to
examine the antigenic substructure of VSPH7 and the extent of antigenic
variation in vivo. VSPH7 proved to be the predominant antigen of the
parasite with respect to serum antibody reactivity. The data indicated that
VSPH7 basically consists of two antigenically distinct parts: (i) a unique,
variant-specific 314-amino- acid N-terminal region which elicits a low
antibody response preferentially detectable during the early phase of the
infection and (ii) a 171-amino-acid C-terminal region which elicits a high
antibody response during the later phase or after resolution of the
infection. The epitopes of the C-terminal region appear to be shared by
other, as yet uncharacterized, variant antigens. The highly conserved
34-amino- acid stretch at the extreme C terminus of VSPH7 exhibited no
immunoreactivity to any of the sera tested. Further investigations
indicated that antigenic variation of the intestinal parasite population
was associated with a diversification into at least six to nine new antigen
types. These variant antigens were extremely heterogeneous in size ranging
from approximately 50 to 115 kDa. None of these proteins shared antigenic
epitopes with the 314-amino-acid N- terminal portion, but several of them
cross-reacted with antibodies specific to the 171-amino-acid C-terminal
portion of the VSP from the original inoculum.
Copyright © 1996, American Society for Microbiology
Serological analysis of antigenic heterogeneity of Giardia lamblia variant surface proteins
Institute of Parasitology, University of Berne, Switzerland.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|